Safe Critical Care: Testing Improvement Strategies
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00975923 |
|
Recruitment Status :
Completed
First Posted : September 14, 2009
Results First Posted : January 12, 2016
Last Update Posted : January 12, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Central Line-associated Bloodstream Infection (CLABSI) Ventilator Associated Pneumonia | Behavioral: Collaborative Group Behavioral: Tool Kit | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 59 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Safe Critical Care: Testing Improvement Strategies |
| Study Start Date : | February 2006 |
| Actual Primary Completion Date : | April 2008 |
| Actual Study Completion Date : | April 2008 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Collaborative Group
Quality Improvement Virtual Learning Collaborative with Interactive Teleconferences and Tool Kit
|
Behavioral: Collaborative Group
In addition to the Tool Kit materials and web site support, facility leaders and managers in this group agreed to participate in a Collaborative to improve critical care. The Collaborative differed from the IHI BTS model in that teams did not come together for face-to-face educational and planning sessions but instead attended web seminars and teleconferences. Between these "virtual" learning sessions, teams implemented some of the suggested change ideas, measured the results of those changes, and reported back to the larger group. Teams were supported through monthly educational and troubleshooting conference calls, individual coaching by faculty members, and an e-mail listserver designed to stimulate interaction among teams.
Other Names:
|
|
Active Comparator: Tool Kit Group
Tool Kit of Evidence-Based Guidelines, Education Seminars, and Aide for Quality Improvement Methods
|
Behavioral: Tool Kit
Hospitals received a tool kit:evidence-based guidelines, CLABSI/VAP fact sheets, change ideas,quality improvement and teamwork methods, standardized data collection and charting tools. Periodic reminders of their commitment to the Safe Critical Care Initiative and access to web site containing all of the educational seminars, clinical tools, and quality improvement tools. ICUs in this group were on their own to initiate and implement a local hospital quality improvement initiative preventing CLABSI and VAP.
Other Name: Quality Improvement |
- CLABSI and VAP Rates [ Time Frame: 18 Months: 3-month baseline and quarterly post-intervention periods ]Central line associated bloodstream infections(CLABSI) and ventilator associated pneumonias (VAP) using Centers for Disease Control and Prevention definitions as number of events per 1,000 device days, data collection and surveillance methods.
- Access of Tools and Use of Quality Improvement Strategies [ Time Frame: 18 months ]Follow-up survey of ICU nurse and quality managers for all participating medical centers from Jan 2008 through April 2008 included questions about the implementation of process interventions: Access and use of clinical guidelines tools, access and use of quality improvement tools, and types of quality improvement implementation strategies.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 1 Year and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Medical centers with at least one adult or pediatric ICU.
- Medical centers within the Hospital Corporation of America (HCA) were eligible for enrollment.
Exclusion Criteria:
- Nonresponse to invitation to participate in our Safe Critical Care Initiative.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00975923
| United States, Tennessee | |
| HCA Hospital Corporation of America | |
| Nashville, Tennessee, United States, 37203 | |
| Principal Investigator: | Theodore Speroff, PhD | Vanderbilt University School of Medicine |
| Responsible Party: | Theodore Speroff, Professor, Vanderbilt University |
| ClinicalTrials.gov Identifier: | NCT00975923 |
| Other Study ID Numbers: |
VU050413 AHRQ U18 HS015934 ( Other Grant/Funding Number: AHRQ U18 015934 ) |
| First Posted: | September 14, 2009 Key Record Dates |
| Results First Posted: | January 12, 2016 |
| Last Update Posted: | January 12, 2016 |
| Last Verified: | December 2015 |
|
Quality Improvement Critical Care Collaboratives Patient Safety Tool Kit |
|
Pneumonia, Ventilator-Associated Sepsis Pneumonia Respiratory Tract Infections Infections Lung Diseases Respiratory Tract Diseases |
Healthcare-Associated Pneumonia Cross Infection Iatrogenic Disease Disease Attributes Pathologic Processes Systemic Inflammatory Response Syndrome Inflammation |

